Welcome! - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Welcome!


Pharmaceutical Technology Europe
Volume 24, Issue 6


Dr Jo Watts
It is with real pleasure that I join the Pharmaceutical Technology Europe (PTE) team. I am honoured to be the Editor of this magazine, especially at such an exciting time. This year celebrates the 35th anniversary of the Pharmaceutical Technology brand, an event that will be celebrated with special feature articles that evaluate the last three and a half decades of developments in the pharmaceutical industry (be sure to check out http://PharmTech.com/ in July for the celebratory retrospectives).

Given the current economic climate, none of us can foresee what the future holds for the industry, but our editorial team will endeavour to continue bringing you relevant, topical and unbiased information. As Editor, I will undertake providing you with engaging, enjoyable content that you will find both interesting and beneficial.

I look forward to meeting some of you at industry events in the coming months and hearing your views on what we can do to make your job easier. We welcome your feedback and participation in our online PharmTechGroup communities on LinkedIn and Twitter.

This month also sees the next ACHEMA event. In current economic times such shows can seem a financial burden, but the chance to meet people face-to-face is becoming less frequent, and to have such large numbers from the industry all under one roof is a compelling enough reason to attend. This year, the majority of the PTE team will be attending the show in Frankfurt. Visit us in hall 3.1, stand J25. You are more than welcome to visit us to let us know what's happening in your corner of the market, or to tell us about something exciting you've seen.

I would like to thank you, European Pharmaceutical Technologists, for your continued support of PTE over the years. With your constant input we will go on making PTE the successful magazine that it is.

Many thanks and best wishes,
Jo Watts, Editor

ADVERTISEMENT

blog comments powered by Disqus
LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
How does your company apply quality-by-design (QbD) principles to manufacturing processes?
To all processes for both new and legacy products
To all process for new products only
To select process for new products only
To select processes for both new and legacy products
Do not use QbD
To all processes for both new and legacy products
20%
To all process for new products only
13%
To select process for new products only
24%
To select processes for both new and legacy products
20%
Do not use QbD
22%
View Results
UPCOMING CONFERENCES

Programs for Investigational and Pre-Launch Drugs
Philadelphia, PA
July 17-18, 2013
Request Brochure

Strategic Pipeline Planning & Portfolio Valuation
Philadelphia, PA
August 13-14, 2013
Request Brochure

MES 2013 - Forum on Manufacturing Execution Systems
Philadelphia, PA
August 14-15, 2013
Request Brochure

Mobile Innovation for the Life Sciences Industry
Philadelphia, PA
August 20-21, 2013
Request Brochure

See All Conferences >>

Eric Langer Outsourcing Outlook Eric LangerOutsourcing's Modest Role as a Cost-Containment Strategy
Patricia Van Arnum Ingredients Insider Patricia Van ArnumIntellectual Property Battles in Solid-State Chemistry
Nathan Jessop Industry Insider Nathan Jessop Campaign Against Counterfeit Drugs Continues
Lynn Torbeck Statistical Solutions Lynn D. TorbeckCompositing Samples and the Risk to Product Quality
 More
Inadequate Access to Medicines Puts EU at Risk
FDA Offers Insight on QbD for Modified-Release Products
Global Biosimilars Market to Reach $2.445 Billion in 2013
Adapting to Change
AstraZeneca and Exco InTouch Collaborate to Augment Current COPD Pathways
FindPharma Custom Search
Source: Pharmaceutical Technology Europe,
Click here